BridgeMD
New treatment option for Type 1 Diabetes
Official title InvesT1D: Promoting Adolescent Investment in Diabetes Care
ClinicalTrials.gov ID: NCT06384911
What this study is testing
- What it's testing
- The goal of this clinical trial is to see if a financial incentives program called InvesT1D is helpful to support diabetes management in adolescents with type 1 diabetes. Adolescent participants will be randomized to usual care or receive financial incentives for meeting diabetes self-management and clinical outcomes goals during the study.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 12 and older
You may be able to join if
- Diagnosed with type 1 diabetes ≥12 months
- Utilize a continuous glucose monitor (CGM) to support diabetes management
- Average daily CGM use is less than or equal to 70% of the time and/or their baseline average insulin bolus administration is less than or equal to 3...
- Are using diabetes technology that allows for tracking of bolus insulin administration if participant wants to work on improving daily bolus insulin...
- Cognitively able to participate in incentive program and complete surveys
You likely can't join if
- At time of screening, average CGM wear is greater than 70% of the time or baseline average insulin bolus administration is greater than 3 times a day
- Adolescent is not interested in using diabetes technology that allows for tracking of bolus insulin administration if participant wants to work on...
- Cognitively or physically unable to participate
- Adolescent is a ward of the state
- Severe comorbidities including other major chronic health conditions that significantly impact daily management demands or health outcomes
- Caregivers are not willing to participate in study and complete surveys
See the full eligibility criteria
- Diagnosed with type 1 diabetes ≥12 months
- Utilize a continuous glucose monitor (CGM) to support diabetes management
- Average daily CGM use is less than or equal to 70% of the time and/or their baseline average insulin bolus administration is less than or equal to 3 times a day
- Are using diabetes technology that allows for tracking of bolus insulin administration if participant wants to work on improving daily bolus insulin administration
- Cognitively able to participate in incentive program and complete surveys
- Have access to a mobile phone to receive information about goal attainment and incentive updates
- Have the ability to upload glucose and insulin administration data remotely per processes used by participant's diabetes care team
- Caregivers are willing to participate in study and complete surveys
- At time of screening, average CGM wear is greater than 70% of the time or baseline average insulin bolus administration is greater than 3 times a day
- Adolescent is not interested in using diabetes technology that allows for tracking of bolus insulin administration if participant wants to work on improving daily bolus insulin administration
- Cognitively or physically unable to participate
- Adolescent is a ward of the state
- Severe comorbidities including other major chronic health conditions that significantly impact daily management demands or health outcomes
- Caregivers are not willing to participate in study and complete surveys
The study team makes the final eligibility decision.
Where it's taking place
- Seattle, Washington, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 12 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Seattle, Washington, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.